Ebola Virus‐Like Particle–Based Vaccine Protects Nonhuman Primates against Lethal Ebola Virus Challenge
Top Cited Papers
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2), S430-S437
- https://doi.org/10.1086/520583
Abstract
Background. Currently, there are no licensed vaccines or therapeutics for the prevention or treatment of infection by the highly lethal filoviruses,Keywords
This publication has 39 references indexed in Scilit:
- Influences of Glycosylation on Antigenicity, Immunogenicity, and Protective Efficacy of Ebola Virus GP DNA VaccinesJournal of Virology, 2007
- Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in MonkeysPLoS Pathogens, 2007
- Protective efficacy of neutralizing antibodies against Ebola virus infectionVaccine, 2006
- Immune Protection of Nonhuman Primates against Ebola Virus with Single Low-Dose Adenovirus Vectors Encoding Modified GPsPLoS Medicine, 2006
- A Single Intranasal Inoculation with a Paramyxovirus-Vectored Vaccine Protects Guinea Pigs against a Lethal-Dose Ebola Virus ChallengeJournal of Virology, 2006
- Protective Cytotoxic T-Cell Responses Induced by Venezuelan Equine Encephalitis Virus Replicons Expressing Ebola Virus ProteinsJournal of Virology, 2005
- Biochemical and Functional Characterization of the Ebola Virus VP24 Protein: Implications for a Role in Virus Assembly and BuddingJournal of Virology, 2003
- Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GPJournal of Virology, 2002
- Lipid Raft MicrodomainsThe Journal of Experimental Medicine, 2002
- The Evolution of Major Histocompatibility Class I Genes in PrimatesCritical Reviews in Immunology, 1995